{"id":5180,"date":"2023-07-25T15:04:04","date_gmt":"2023-07-25T15:04:04","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=5180"},"modified":"2023-08-07T15:13:56","modified_gmt":"2023-08-07T15:13:56","slug":"west-african-journal-of-pharmacy-2014-25-2-125-136","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2014-25-2-125-136\/","title":{"rendered":"West African Journal of Pharmacy (2014) 25 (2) 125-136"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

The economic, psychosocial burden and State ownership of HIV\/AIDS Programme in Nasarawa State, Nigeria<\/b><\/p>

\u00a0<\/p>

Benjamin N Joseph , Noel N Wannang, Dauda A Dangiwa, Maxwell P Dapar\u00a0Department of Clinical Pharmacy and Pharmacy Practice; Department of Pharmacology,\u00a0<\/span>Faculty of Pharmaceutical Sciences, University of Jos, Nigeria.<\/span><\/p>

\u00a0<\/span><\/p>

Corresponding Author: Benjamin N Joseph<\/p>

E-mail: jbnasara2002@yahoo.com Phone: +2348036451056<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Background:<\/b> Nasarawa State has a high HIV prevalence rate of 7.5%. This may adversely affect the socio-economic and psychological wellbeing of people living with HIV.<\/span><\/p>

Objectives: <\/b>This study sought to examine the economic and psychosocial burden of HIV on infected people and\u00a0assess the preparedness of the State government towards HIV\/AIDS ownership and sustainability.<\/span><\/p>

Method: <\/b>The study design is descriptive cross-sectional survey involving 312 respondents’ randomly selected\u00a0from 6 hospitals following a two stage stratified sampling across the State.<\/span><\/p>

Results:<\/b> Respondents’ with the lowest discretional income 41 (44.6%) p-values 0.006 and those with the lowest\u00a0educational status 24 (55.8%) p-values 0.032 were significantly associated with higher CD4 counts (\u2265<\/span>3\u00a0<\/span>350cells\/mm ). Statistical association exists between stigmatizing attitudes and ART adherence; respondents’\u00a0<\/span>who rejected stigmatizing attitudes, stereotypes and negative perceptions ascribed to them by the society\u00a0<\/span>recorded significant difference in adherence to medication 92 (98.9%), p-value 0.000; 57 (100%) p-value 0.016;<\/span>91 (96.8%) p-value 0.009; and 80 (97.6%) with p-value 0.024. Laboratory parameters indicated that packed cell\u00a0<\/span>volume, haemoglobin and CD values before HAART and pre-data collection were below normal values. A Chi- 4\u00a0<\/span>square test indicated significant difference between the State owned drug revolving fund and the assisted\u00a0<\/span>2 2\u00a0<\/span>(donor-funded) ART scheme; X = 152.66, Critical X = 11.07.<\/span><\/p>

Conclusion:<\/b> Respondents’ with strong coping mechanism rejected the stigmatizing attributes ascribed to them\u00a0thereby achieving the recommended level of adherence; poor socio-economic groups recorded better\u00a0<\/span>treatment outcomes. This study revealed that the State has not shown significant commitment toward the\u00a0<\/span>sustainable provision of HIV\/AIDS scheme.<\/span><\/p>

Keywords: <\/b>HIV\/AIDS, Economic, Psychosocial, Nigeria<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tDownload <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

The economic, psychosocial burden and State ownership of HIV\/AIDS Programme in Nasarawa State, Nigeria \u00a0 Benjamin N Joseph , Noel N Wannang, Dauda A Dangiwa, Maxwell P Dapar\u00a0Department of Clinical Pharmacy and Pharmacy Practice; Department of Pharmacology,\u00a0Faculty of Pharmaceutical Sciences, University of Jos, Nigeria. \u00a0 Corresponding Author: Benjamin N Joseph E-mail: jbnasara2002@yahoo.com Phone: +2348036451056 ABSTRACT […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/5180"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=5180"}],"version-history":[{"count":4,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/5180\/revisions"}],"predecessor-version":[{"id":5186,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/5180\/revisions\/5186"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=5180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=5180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=5180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}